Morris RE et al. |
Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689885
|
Todo S et al. |
Early trials with FK 506 as primary treatment in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689886
|
McCauley J et al. |
The effects of FK 506 on renal function after liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689887
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Morimoto T et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the dog. |
1990 |
Transplant. Proc. |
pmid:1691550
|
Justice RM et al. |
The detection of proline isomerase activity in FK506-binding protein by two-dimensional 1H NMR exchange spectroscopy. |
1990 |
Biochem. Biophys. Res. Commun. |
pmid:1697463
|
Todo S et al. |
Liver, kidney, and thoracic organ transplantation under FK 506. |
1990 |
Ann. Surg. |
pmid:1697743
|
Isai H et al. |
FK 506 and orthotopic liver transplantation in the rat. |
1990 |
Transplant. Proc. |
pmid:1699329
|
Mochizuki M and Kawashima H |
Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. |
1990 |
Autoimmunity |
pmid:1717007
|